SCHEMBL2896716

SCHEMBL2896716

O=C1C(=Cc2ccc(-c3ccccc3)o2)SC(=S)N1C1CCCCCC1

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 7/20 0.69
KMT2A Q03164 7/20 0.69
POLB P06746 8/20 0.64
MAPT P10636 5/20 0.64
ALDH1A1 P00352 5/20 0.64
LMNA P02545 2/20 0.64
RAB9A P51151 1/20 0.64
ALPL P05186 1/20 0.59
ALPI P09923 1/20 0.59
ALPG P10696 1/20 0.59
MCL1 Q07820 1/20 0.59
L3MBTL1 Q9Y468 3/20 0.53
MAPK1 P28482 1/20 0.53
PIK3CG P48736 1/20 0.50
HSD17B3 P37058 1/20 0.49
DNMT1 P26358 1/20 0.48
BLM P54132 1/20 0.48
HTT P42858 1/20 0.48
SMN1; SMN2 Q16637 1/20 0.48
KDM4E B2RXH2 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2897859 1.00 MEN1 (0.69) MEN1KMT2APOLBMAPTALDH1A1
SCHEMBL2898196 1.00 MEN1 (0.69) MEN1KMT2APOLBMAPTALDH1A1
SCHEMBL2896713 1.00 MEN1 (0.69) MEN1KMT2APOLBMAPTALDH1A1
SCHEMBL2896709 1.00 MEN1 (0.69) MEN1KMT2APOLBMAPTALDH1A1
SCHEMBL13220180 1.00 MEN1 (0.69) MEN1KMT2APOLBMAPTALDH1A1
SCHEMBL13025036 1.00 MEN1 (0.69) MEN1KMT2APOLBMAPTALDH1A1
SCHEMBL2898197 1.00 MEN1 (0.69) MEN1KMT2APOLBMAPTALDH1A1
SCHEMBL2897863 1.00 MEN1 (0.69) MEN1KMT2APOLBMAPTALDH1A1
SCHEMBL2898198 1.00 MEN1 (0.69) MEN1KMT2APOLBMAPTALDH1A1
SCHEMBL2897860 1.00 MEN1 (0.69) MEN1KMT2APOLBMAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8466177-B2 Treating and preventing viral infections THE UAB RESEARCH FOUNDATION (US) 2013-06-18 US disclosed
US-20100286212-A1 Treating and Preventing Viral Infections THE UAB RESEARCH FOUNDATION (US) 2010-11-11 US disclosed
EP-2217573-A1 TREATING AND PREVENTING VIRAL INFECTIONS The UAB Research Foundation (US) 2010-08-18 EP disclosed
WO-2009059243-A1 TREATING AND PREVENTING VIRAL INFECTIONS THE UAB RESEARCH FOUNDATION (US) 2009-05-07 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100286212-A1 Treating and Preventing Viral Infections HAVCR2, IRF3, MAVS MEN1 3172/4885KMT2A 3809/4885POLB 313/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.